HSTM insider buying and SEC filings, explained
Healthstream Inc. · CIK 1095565
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Services-Computer Programming, Data Processing, Etc.
- State of incorporation
- TN
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$4.5M
Planned sales (10b5-1)
$694K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 23, 2026 | Planned (10b5-1) | Linda Rebrovick (Director) sold 12,000 shares at $35.00 ($420K), marked as a 10b5-1 plan trade. Holdings down 23% to 39,329 shares. | SEC filing Filed Oct 23, 2026, 4:54 PM ET |
| Sep 14, 2026 | Sale | Robert A. Frist Jr. (CEO and Director) sold 144,068 shares at $29.50 ($4.3M). Holdings down 4% to 3,907,038 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 15, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | Linda Rebrovick (Director) sold 6,000 shares at $29.00 ($174K), marked as a 10b5-1 plan trade. Holdings down 10% to 51,329 shares. | SEC filing Filed Jul 7, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Linda Rebrovick (Director) sold 2,000 shares at $25.00 ($50K), marked as a 10b5-1 plan trade. Holdings down 4% to 54,181 shares. | SEC filing Filed Jun 2, 2026 |
| May 28, 2026 | Planned (10b5-1) | Linda Rebrovick (Director) sold 2,000 shares at $25.00 ($50K), marked as a 10b5-1 plan trade. Holdings down 3% to 56,181 shares. | SEC filing Filed Jun 1, 2026 |
| May 20, 2026 | Sale | Kevin P O'Hara (Executive Vice President) sold 3,000 shares at about $24.08 ($72K). Holdings down 13% to 20,982 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 20, 2026 |
| Dec 10, 2025 | Sale | Jeff Cunningham (Chief Technology Officer) sold 2,100 shares at about $24.09 ($51K). Holdings down 6% to 31,489 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 10, 2025 |
| Dec 8, 2025 | Sale | Kevin P O'Hara (Executive Vice President) sold 2,000 shares at about $24.26 ($49K). Holdings down 11% to 16,373 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 8, 2025 |
| Nov 26, 2025 | Sale | Tate Deborah Taylor (Director) sold 1,580 shares at about $25.46 ($40K). Holdings down 6% to 23,127 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 1, 2025 |
79 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:35 PM ET 8-K | Earnings released (Item 2.02) Reg FD disclosure (Item 7.01) Other event (Item 8.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow HSTM in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.